Relief Therapeutics Holding AG (RLFTF)

[elllk]

On the issue of long haul COVID here is one possibility that Aviptadil helps control:

"We are finding elevated cytokines in long-COVID patients and we're trying to decode what those cytokines mean. We're also seeing some distinct autoantibody reactivity and are trying to find out what those antibodies are doing and whether they are causing harm" Akiko Iwasaki says.

New clues to the biology of long COVID are starting to emerge https://www.npr.org/sections/health-shots/2021/11/12/1053509795/long-covid-causes-treatment-clues?utm_campaign=storyshare&utm_source=twitter.com&utm_medium=social